SAMANTHA WHEELAND: Open Payments
NPI 1861809485 · MONTOURSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 56 payments from 16 companies in 2025. Trend: 2023 $990 · 2024 $1,131 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $163 |
| Lilly USA, LLC | 7 | $134 |
| ABBVIE INC. | 5 | $122 |
| Novo Nordisk Inc | 6 | $120 |
| Exact Sciences Corporation | 5 | $116 |
| Dexcom, Inc. | 4 | $90 |
| Astellas Pharma US Inc | 3 | $75 |
| Medtronic, Inc. | 2 | $71 |
| Amgen Inc. | 4 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
Products named: QULIPTA, AIRSUPRA, MOUNJARO, Dexcom G6 Transmitter, Ozempic, JARDIANCE, Veozah, Cologuard Collection Kit.
Industry payments across PA — which companies pay providers there.
